Cindy Delbrook
Publications by Year
Research Areas
CAR-T cell therapy research, Acute Lymphoblastic Leukemia research, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction
Most-Cited Works
- → T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial(2014)2,912 cited
- → CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy(2017)1,320 cited
- → CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial(2020)406 cited
- → Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL(2021)346 cited
- → Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid Tumors(2015)323 cited
- → Characterization of CD22 expression in acute lymphoblastic leukemia(2015)172 cited
- → Sequential loss of tumor surface antigens following chimeric antigen receptor T-cell therapies in diffuse large B-cell lymphoma(2018)169 cited
- → Long-Term Outcomes Following CD19 CAR T Cell Therapy for B-ALL Are Superior in Patients Receiving a Fludarabine/Cyclophosphamide Preparative Regimen and Post-CAR Hematopoietic Stem Cell Transplantation(2016)118 cited
- → Impact of cytokine release syndrome on cardiac function following CD19 CAR-T cell therapy in children and young adults with hematological malignancies(2020)98 cited
- → Systematic Evaluation of Neurotoxicity in Children and Young Adults Undergoing CD22 Chimeric Antigen Receptor T-Cell Therapy(2018)83 cited